Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Cited by (1,053)

Items 401–500 of 1,053

1. Persistent Inflammation as a Catalyst for Other Risk Factors in Chronic Kidney Disease
   Juan Jesús Carrero, Peter Stenvinkel · 2009 · Clinical Journal of the American Society of Nephrology
2. RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist
   Kevin G. McLure, Emily M. Gesner, Laura M. Tsujikawa, Olesya A. Kharenko, Sarah Attwell, Eric Campeau, Sylwia Wasiak, Adam J. Stein, André White, Eric Fontano et al. · 2013 · PLoS ONE
3. Gender Differences in Cardiovascular Disease: Hormonal and Biochemical Influences
   Faustino Ramón Pérez-López, Luis Larrad-Mur, Amanda Nicole Kallen, Peter A. Chedraui, Hugh Stott Taylor · 2010 · Reproductive Sciences
4. Cardiovascular Drug Development
   Fordyce, Christopher B., Roe, Matthew T., Ahmad, Tariq, Libby, Peter, Borer, Jeffrey S., Hiatt, William R., Bristow, Michael R., Packer, Milton, Wasserman, Scott M., Braunstein, Ned et al. · 2015 · Journal of the American College of Cardiology
5. 2015 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension
   Chern‐En Chiang, Tzung‐Dau Wang, Kwo-Chang Ueng, Tsung‐Hsien Lin, Hung‐I Yeh, Chung-Yin Chen, Yih-Jer Wu, Wei‐Chuan Tsai, Ting‐Hsing Chao, Chen-Huan Chen et al. · 2014 · Journal of the Chinese Medical Association
6. Autophagy: Regulation and role in disease
   Alfred J. Meijer, Patrice Codogno · 2009 · Critical Reviews in Clinical Laboratory Sciences
7. Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-Analysis
   Boekholdt, S. Matthijs, Arsenault, Benoit J., Hovingh, G. Kees, Mora, Samia, Pedersen, Terje R., LaRosa, John C., Welch, K.M.A., Amarenco, Pierre, DeMicco, David A., Tonkin, Andrew M. et al. · 2013 · Circulation
8. <scp>Glucagon‐like peptide‐1 receptor agonists</scp> improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials
   Bray, Jonathan J. H., Foster‐Davies, Harri, Salem, Ahmed, Hoole, Amy L., Obaid, Daniel R., Halcox, Julian P. J., Stephens, Jeffrey W. · 2021 · Diabetes Obesity and Metabolism
9. Innate immune signals in atherosclerosis
   Anna M. Lundberg, Göran K. Hansson · 2009 · Clinical Immunology
10. Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications
    Massimiliano Ruscica, Nicola Ferri, Maciej Banach, Cesare Riccardo Sirtori, Alberto Corsini · 2022 · Cardiovascular Research
11. Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug Development
    Sebastian Schneeweiß, J J Gagne, Robert J. Glynn, Michael Rühl, Jeremy A. Rassen · 2011 · Clinical Pharmacology & Therapeutics
12. Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease
    Kyle A. Nelson, Valentı́n Fuster, Paul M. Ridker · 2023 · Journal of the American College of Cardiology
13. Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
    Kaddurah-Daouk, Rima, Baillie, Rebecca A., Zhu, Hongjie, Zeng, Zhao-Bang, Wiest, Michelle M., Nguyen, Uyen Thao, Wojnoonski, Katie, Watkins, Steven M., Trupp, Miles, Krauss, Ronald M. · 2011 · PLoS ONE
14. 2018 Guidelines for the Management of Dyslipidemia in Korea
    Eun‐Jung Rhee, Hyeon Chang Kim, Jae Hyeon Kim, Eun Young Lee, Byung Jin Kim, Eun Mi Kim, YoonJu Song, Jeong Hyun Lim, Byung Jin Kim, Seonghoon Choi et al. · 2019 · Journal of Lipid and Atherosclerosis
15. The Evolving Understanding and Approach to Residual Cardiovascular Risk Management
    Devinder Singh Dhindsa, Pratik B. Sandesara, Michael David Shapiro, Nathan D. Wong · 2020 · Frontiers in Cardiovascular Medicine
16. Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement
    George A. Mensah, Natalie Arnold, Sumanth D. Prabhu, Paul M. Ridker, Francine K. Welty · 2025 · Journal of the American College of Cardiology
17. ESC/EAS Guidelines for the management of dyslipidaemias
    Catapano, Alberico L., Reiner, Željko, De Backer, Guy, Graham, Ian, Taskinen, Marja-Riitta, Wiklund, Olov, Agewall, Stefan, Alegria, Eduardo, Chapman, M. John, Durrington, Paul et al. · 2011 · Atherosclerosis
18. Presence of Coronary Plaques in Patients with Nonalcoholic Fatty Liver Disease
    Nimer Assy, Agness Djibre, Raymond E Farah, Maria Grosovski, Alon T Marmor · 2010 · Radiology
19. PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia
    Sophie J. Bernelot Moens, Annette E. Neele, Jeffrey Kroon, Fleur M. van der Valk, Jan Van den Bossche, Marten A. Hoeksema, Renate M. Hoogeveen, Johan G. Schnitzler, Marie T. Baccara‐Dinet, Garen Z. Manvelian et al. · 2017 · European Heart Journal
20. Metabolic inflammation: Connecting obesity and insulin resistance
    Nassim Dali‐Youcef, Mustapha Mecili, Roméo Ricci, Emmanuel Andrès · 2012 · Annals of Medicine
21. Stroke Prevention - Medical and Lifestyle Measures
    Hakan Sarıkaya, José Manuel Ferro, Marcel Arnold · 2015 · European Neurology
22. State of the Science in Women's Cardiovascular Disease: A Canadian Perspective on the Influence of Sex and Gender
    Colleen M. Norris, Cindy Ying Yin Yip, Kara A. Nerenberg, Marie-Annick A Clavel, Christine Pacheco, Heather J.A. Foulds, Marsha Hardy, Christine A. Gonsalves, Shahin Jaffer, Monica J. E. Parry et al. · 2020 · Journal of the American Heart Association
23. Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group
    Holly C. Gooding, Samuel S. Gidding, Andrew Edward Moran, Nicole Redmond, Norrina B. Allen, Fida F Bacha, Trudy L. Burns, Janet M. Catov, Michael A. Grandner, Kathleen Mullan Harris et al. · 2020 · Journal of the American Heart Association
24. Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation
    George S. Abela · 2010 · Journal of clinical lipidology
25. Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target
    Nadezhda Glezeva, John Andrew Baugh · 2013 · Heart Failure Reviews
26. Rationale and Methods of the Study on Nutrition and Cardiovascular Risk in Spain (ENRICA)
    Fernando Rodríguez‐Artalejo, Auxiliadora Graciani, Pilar Guallar‐Castillón, Luz María León-Muñoz, M. Clemencia Zuluaga, Esther López‐García, Juan Luis Gutiérrez-Fisac, José M. Taboada, María Teresa Aguilera, Enrique Regidor et al. · 2011 · Revista Española de Cardiología (English Edition)
27. Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants
    Wang, Nelson, Fulcher, Jordan, Abeysuriya, Nishan, Park, Laura, Kumar, Shejil, Di Tanna, Gian Luca, Wilcox, Ian, Keech, Anthony, Rodgers, Anthony, Lal, Sean · 2020 · The Lancet Diabetes &amp; Endocrinology
28. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial
    Vallejo-Vaz, Antonio J., Fayyad, Rana, Boekholdt, S. Matthijs, Hovingh, G. Kees, Kastelein, John J., Melamed, Shari, Barter, Philip, Waters, David D., Ray, Kausik K. · 2018 · Circulation
29. Innate and Adaptive Inflammation as a Therapeutic Target in Vascular Disease
    Tousoulis, Dimitris, Psarros, Costas, Demosthenous, Michael, Patel, Rikhil, Antoniades, Charalambos, Stefanadis, Christodoulos · 2014 · Journal of the American College of Cardiology
30. Risk Factors and Drug Interactions Predisposing to Statin-Induced Myopathy
    Yiannis S. Chatzizisis, Konstantinos C. Koskinas, Gesthimani Misirli, Christos Vaklavas, Apostolos Ioannis Hatzitolios, George D. Giannoglou · 2010 · Drug Safety
31. Statins and Intracerebral Hemorrhage
    Daniel G. Hackam, Mark Woodward, Laura Kristin Newby, Deepak L. Bhatt, Mingyuan Shao, Eric Edward Smith, Allan Donner, Muhammad Mamdani, James Demetrios Douketis, Hisatomi Arima et al. · 2011 · Circulation
32. Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Proceedings of a Canadian Working Group Consensus Conference
    G.B. John Mancini, Steven K. Baker, Jean Bergeron, DAVID H. FITCHETT, Jiri J Frohlich, Jacques J. Genest, Milan Gupta, Robert Alexander Hegele, Dominic S. Ng, Janet Elizabeth Pope · 2011 · Canadian Journal of Cardiology
33. Differing effect of statins on insulin sensitivity in non-diabetics: A systematic review and meta-analysis
    William L. Baker, Ripple Talati, Charles Michael White, Craig Ian Coleman · 2009 · Diabetes Research and Clinical Practice
34. Targeting inflammation in diabetes: Newer therapeutic options
    Neeraj Kumar Agrawal · 2014 · World Journal of Diabetes
35. Socioeconomic and psychosocial predictors of interleukin-6 in the MIDUS national sample
    Morozink, Jennifer A., Friedman, Elliot M., Coe, Christopher L., Ryff, Carol D. · 2010 · Health Psychology
36. Cardiometabolic Risk in Canada: A Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group
    Lawrence A. Leiter, DAVID H. FITCHETT, Richard E. Gilbert, Milan Gupta, G.B. John Mancini, Philip A. McFarlane, Robert Ross, Hwee Teoh, Subodh Verma, Sonia Savitri Anand et al. · 2011 · Canadian Journal of Cardiology
37. Cardiovascular drug therapy in the elderly: benefits and challenges
    Fleg, Jerome L., Aronow, Wilbert S., Frishman, William H. · 2011 · Nature Reviews Cardiology
38. Depletion of B2 but Not B1a B Cells in BAFF Receptor-Deficient ApoE−/− Mice Attenuates Atherosclerosis by Potently Ameliorating Arterial Inflammation
    Tin Soe Kyaw, Christopher Tay, Hamid Hosseini, Peter Kanellakis, T. Gadowski, Fabienne Mackay, Peter G. Tipping, Alex Bobik, Ban‐Hock Toh · 2012 · PLoS ONE
39. Ischemic heart disease in women: A focus on risk factors
    Puja K. Mehta, Janet Wei, NANETTE KASS WENGER · 2014 · Trends in Cardiovascular Medicine
40. Anti‐Inflammatory Effects of a Vegan Diet Versus the American Heart Association–Recommended Diet in Coronary Artery Disease Trial
    Binita Shah, Jonathan D. Newman, Kathleen Woolf, Lisa Ganguzza, Yu Guo, Nicole Allen, Judy Zhong, Edward A A Fisher, James N. Slater · 2018 · Journal of the American Heart Association
41. Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice
    Fumitake Usui, Koumei Shirasuna, Hiroaki J. Kimura, Kazuki Tatsumi, Akira Kawashima, Tadayoshi Karasawa, Shigeaki Hida, Junji Sagara, Shun’ichiro Taniguchi, Masafumi Takahashi · 2012 · Biochemical and Biophysical Research Communications
42. How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease
    Valentina O. Püntmann · 2009 · Postgraduate Medical Journal
43. Effect of Intensive Versus Moderate Lipid-Lowering Therapy on Epicardial Adipose Tissue in Hyperlipidemic Post-Menopausal Women
    Nikolaos A. Alexopoulos, Bekir H. Melek, Chesnal Dey Arepalli, Gregory Randell Hartlage, Zhengjia Chen, Sungjin Kim, Arthur E. Stillman, Paolo Raggi · 2013 · Journal of the American College of Cardiology
44. C-reactive protein: a target for therapy to reduce inflammation
    Salma A. Rizo-Téllez, Meriem Sekheri, János G. Filep · 2023 · Frontiers in Immunology
45. A Randomized Study of How Physicians Interpret Research Funding Disclosures
    Kesselheim, Aaron S., Robertson, Christopher T., Myers, Jessica A., Rose, Susannah L., Gillet, Victoria, Ross, Kathryn M., Glynn, Robert J., Joffe, Steven, Avorn, Jerry · 2012 · New England Journal of Medicine
46. Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: Insights from the National Health and Nutrition Examination Survey-III
    Neeraj Nailesh Shah, Valay K. Parikh, Nileshkumar Patel, Nilay Patel, Apurva Badheka, Abhishek J. Deshmukh, Ankit Dineshbhai Rathod, James Lafferty · 2013 · International Journal of Cardiology
47. Vascular Dysfunction in Chronic Obstructive Pulmonary Disease
    John D. Maclay, David McAllister, Nicholas L. Mills, Finny Paterson, Christopher A. Ludlam, Ellen Drost, David Ernest Newby, William MacNee · 2009 · American Journal of Respiratory and Critical Care Medicine
48. Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19
    Aakriti Gupta, Mahesh V. Madhavan, Timothy Joseph Poterucha, Ersilia M. DeFilippis, Jessica A. Hennessey, Björn Redfors, Christina M. Eckhardt, Behnood Bikdeli, Jonathan Platt, Ani Nalbandian et al. · 2021 · Nature Communications
49. Lipid-Modifying Therapies and Risk of Pancreatitis: A Meta-analysis
    Preiss, David, Tikkanen, Matti J., Welsh, Paul, Ford, Ian, Lovato, Laura C., Elam, Marshall B., LaRosa, John C., DeMicco, David A., Colhoun, Helen M., Goldenberg, Ilan et al. · 2012 · JAMA
50. Aneurysm sac failure to regress after endovascular aneurysm repair is associated with lower long-term survival
    Thomas F.X. O’Donnell, Sarah E. Deery, Laura T. Boitano, Jeffrey J. Siracuse, Marc L. Schermerhorn, Salvatore T. Scali, Andres S. Schanzer, Robert Todd Lancaster, Virendra I. Patel · 2018 · Journal of Vascular Surgery
51. Imaging residual inflammatory cardiovascular risk
    Charalambos A. Antoniades, Alexios S. Antonopoulos, John Eric Deanfield · 2019 · European Heart Journal
52. Coronary and carotid atherosclerosis: Similarities and differences
    Fisnik Jashari, Pranvera Ibrahimi, Rachel Nicoll, Gani Bajraktari, Per Olov Wester, Michael Y. Henein · 2012 · Atherosclerosis
53. Estimating treatment effects for individual patients based on the results of randomised clinical trials
    Dorresteijn, J. A. N., Visseren, F. L. J., Ridker, P. M., Wassink, A. M. J., Paynter, N. P., Steyerberg, E. W., van der Graaf, Y., Cook, N. R. · 2011 · BMJ
54. Serial Coronary CT Angiography–Verified Changes in Plaque Characteristics as an End Point
    Kaori Inoue, Sadako Motoyama, Masayoshi Sarai, Takahisa Sato, Hiroto Harigaya, Tomonori Hara, Yoshihiro Sanda, Hirofumi Anno, Takeshi Kondo, Nathan D. Wong et al. · 2010 · JACC. Cardiovascular imaging
55. Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: U.S. Preventive Services Task Force Recommendation Statement
    U.S. Preventive Services Task Force* · 2009 · Annals of Internal Medicine
56. Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants
    Henock G. Yebyo, Hélène Eloise Aschmann, Marco Kaufmann, Milo Alan Puhan · 2019 · American Heart Journal
57. Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults
    Benjamin H. Han, David G. Sutin, Jeff D. Williamson, Barry R. Davis, Linda B. Piller, Hannah Pervin, Sara Pressel, Caroline S. Blaum · 2017 · JAMA Internal Medicine
58. Effect of statin therapy on colorectal cancer
    Marc Bardou, Alan N. Barkun, Myriam Martel · 2010 · Gut
59. Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia
    Ballantyne, Christie M., Davidson, Michael H., MacDougall, Diane E., Bays, Harold E., DiCarlo, Lorenzo A., Rosenberg, Noah L., Margulies, Janice, Newton, Roger S. · 2013 · Journal of the American College of Cardiology
60. C-Reactive Protein and Prediction of 1-Year Mortality in Prevalent Hemodialysis Patients
    Jonathan W. Bazeley, Brian A. Bieber, Yun Li, Hal Morgenstern, Patricia de Sequera, Christian Combe, Hiroyasu Yamamoto, Martin Gallagher, Friedrich K. Port, Bruce M. Robinson · 2011 · Clinical Journal of the American Society of Nephrology
61. Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk
    Paul M. Ridker · 2018 · Journal of the American College of Cardiology
62. Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline
    Connie B. Newman, Michael Joseph Blaha, Jeffrey B. Boord, Bertrand Cariou, Alan Chait, Henry G. Fein, Henry N. Ginsberg, Ira J. Goldberg, Mohammad Hassan Murad, Savitha Subramanian et al. · 2020 · The Journal of Clinical Endocrinology & Metabolism
63. Cost-Effectiveness of Statin Therapy for Primary Prevention in a Low-Cost Statin Era
    Lawrence D. Lazar, Mark J. Pletcher, Pamela G. Coxson, Kirsten B. Bibbins-Domingo, Lee Goldman · 2011 · Circulation
64. Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
    Aaron W. Aday, Paul M. Ridker · 2019 · Frontiers in Cardiovascular Medicine
65. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction
    S. Murphy, C. Cannon, S. Wiviott, C. McCabe, E. Braunwald · 2009 · Journal of the American College of Cardiology
66. Serum, plasma, and dried blood spot high-sensitivity C-reactive protein enzyme immunoassay for population research
    Eleanor Brindle, Masako Fujita, Jane B. Shofer, Kathleen A. O’Connor · 2010 · Journal of Immunological Methods
67. The diabetogenic action of statins — mechanisms and clinical implications
    D. J. Betteridge, Rafael Carmena · 2015 · Nature Reviews Endocrinology
68. Evidence of Pre-Procedural Statin Therapy
    David E. Winchester, Xuerong Wen, Lola X. Xie, Anthony A. Bavry · 2010 · Journal of the American College of Cardiology
69. No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY phase 3 studies
    Colhoun, Helen M., Ginsberg, Henry N., Robinson, Jennifer G., Leiter, Lawrence A., Müller-Wieland, Dirk, Henry, Robert R., Cariou, Bertrand, Baccara-Dinet, Marie T., Pordy, Robert, Merlet, Laurence et al. · 2016 · European Heart Journal
70. The role of heat shock proteins in atherosclerosis
    Georg Wick, Bojana Jakic, Maja Buszko, Marius C. Wick, Cecilia Grundtman · 2014 · Nature Reviews Cardiology
71. Non-cardiovascular effects associated with statins
    C. S. Desai, Seth Shay Martin, Roger Scott Blumenthal · 2014 · BMJ
72. Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
    Allison B. Goldfine, Steven E. Shoelson · 2017 · Journal of Clinical Investigation
73. Statin use and risk of new-onset diabetes: A meta-analysis of observational studies
    Manuela Casula, Francesco Mozzanica, Lorenza Scotti, Elena Tragni, Angela Pirillo, Giovanni Corrao, Alberico Luigi Catapano · 2017 · Nutrition Metabolism and Cardiovascular Diseases
74. Novel findings in neutrophil biology and their impact on cardiovascular disease
    Aldo Bonaventura, Fabrizio Montecucco, Franco Dallegri, Federico Carbone, Thomas Felix Lüscher, Giovanni Guido Camici, Luca Liberale · 2019 · Cardiovascular Research
75. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease
    Behzad Yeganeh, Emilia Wiecheć, Sudharsana Rao Ande, Pawan Kumar Sharma, Adel Rezaei Moghadam, Martin Post, Darren H. Freed, Mohammad Mostakhdem Hashemi, Shahla Shojaei, Amir A. Zeki et al. · 2014 · Pharmacology & Therapeutics
76. C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians
    Windgassen, Elizabeth B., Funtowicz, Luciana, Lunsford, Tisha N., Harris, Lucinda A., Mulvagh, Sharon L. · 2011 · Postgraduate Medicine
77. Quantification of Coronary Atherosclerosis and Inflammation to Predict Coronary Events and All-Cause Mortality
    Stefan Möhlenkamp, Nils Lehmann, Susanne Moebus, Axel Schmermund, Nico Dragano, Andreas Stang, Johannés Siegrist, Klaus Mann, Karl‐Heinz Jöckel, Raimund M. Erbel · 2011 · Journal of the American College of Cardiology
78. Prognostic and Therapeutic Implications of Statin and Aspirin Therapy in Individuals With Nonobstructive Coronary Artery Disease
    Benjamin J.W. Chow, Gary R. Small, Yeung Yam, Li Chen, Ruth McPherson, Stephan S. Achenbach, Mouaz Husayn Al-Mallah, Daniel S. Berman, Matthew Jay Budoff, Filippo Cademartiri et al. · 2015 · Arteriosclerosis Thrombosis and Vascular Biology
79. Distribution of Inflammation Within Carotid Atherosclerotic Plaques With High-Risk Morphological Features
    Amparo L. Figueroa, Sharath S. Subramanian, Ricardo Caldeira Cury, Quynh A. Truong, Joseph A. Gardecki, Guillermo J. Tearney, Udo Hoffmann, Thomas J. Brady, Ahmed A Tawakol · 2011 · Circulation Cardiovascular Imaging
80. Rosuvastatin in the Prevention of Stroke Among Men and Women With Elevated Levels of C-Reactive Protein
    Brendan M. Everett, Robert J. Glynn, Jean G. MacFadyen, Paul M. Ridker · 2009 · Circulation
81. Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
    Majed M. Masadeh, Nizar Mahmoud Mhaidat, Karem Hasan Alzoubi, Sayer I. Al-Azzam, Ziad Alnasser · 2012 · Annals of Clinical Microbiology and Antimicrobials
82. Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies
    Roland Klingenberg, Göran K. Hansson · 2009 · European Heart Journal
83. Association of statin prescription with small abdominal aortic aneurysm progression
    Craig D. Ferguson, Paula Clancy, Bernard M. Bourke, Philip J. Walker, Anthony E. Dear, Tim M Buckenham, Paul E Norman, Jonathan Golledge · 2010 · American Heart Journal
84. Statins in Familial Hypercholesterolemia
    Joost Besseling, G. Kees Hovingh, Roeland Huijgen, John J.P. Kastelein, Barbara A. Hutten · 2016 · Journal of the American College of Cardiology
85. Inflammation as a Therapeutic Target in Atherosclerosis
    Mau T. Nguyen, Sanuja Fernando, Nisha Schwarz, Joanne T. M. Tan, Christina A. Bursill, Peter James Psaltis · 2019 · Journal of Clinical Medicine
86. The Biological Role of Inflammation in Atherosclerosis
    Wong, Brian W., Meredith, Anna, Lin, David, McManus, Bruce M. · 2012 · Canadian Journal of Cardiology
87. The JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms
    Chiara Baldini, Francesca Romana Moriconi, Sara Galimberti, Peter Libby, Raffaele De Caterina · 2021 · European Heart Journal
88. The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: An updated meta-analysis
    Philippa J. Delahoy, Dianna J. Magliano, Kate Webb, Mendel P. Grobler, Danny Liew · 2009 · Clinical Therapeutics
89. Relation of Microchannel Structure Identified by Optical Coherence Tomography to Plaque Vulnerability in Patients With Coronary Artery Disease
    Hironori Kitabata, Atsushi Tanaka, Takashi Kubo, Shigeho Takarada, Manabu Kashiwagi, Hiroto Tsujioka, Hideyuki Ikejima, Akio Kuroi, Hideaki Kataiwa, Kohei Ishibashi et al. · 2010 · The American Journal of Cardiology
90. Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis
    Xiaole Su, Lu Zhang, Jicheng Lv, Jinwei Wang, Wanyin Hou, Xinfang Xie, Hong Zhang · 2016 · American Journal of Kidney Diseases
91. Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke
    Aldo Bonaventura, Luca Liberale, Alessandra Vecchié, Matteo Casula, Federico Carbone, Franco Dallegri, Fabrizio Montecucco · 2016 · International Journal of Molecular Sciences
92. An assessment by the Statin Intolerance Panel: 2014 update
    Guyton, John R., Bays, Harold E., Grundy, Scott M., Jacobson, Terry A. · 2014 · Journal of clinical lipidology
93. Recent advances in pharmacotherapy for hypertriglyceridemia
    Amirhossein Sahebkar, Gerard T. Chew, Gerald Francis Watts · 2014 · Progress in Lipid Research
94. Knee osteoarthritis in obese women with cardiometabolic clustering
    MaryFran Sowers, Carrie A Karvonen-Gutierrez, Riann M. Palmieri‐Smith, Jon A. Jacobson, Yebin Jiang, James A. Ashton‐Miller · 2009 · Arthritis Care & Research
95. Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
    Paul M. Ridker, Jean G. MacFadyen, Francisco Antônio Helfenstein Fonseca, Jacques J. Genest, Antonio M. Gotto, John J.P. Kastelein, Wolfgang Köenig, Peter Libby, Alberto J. Lorenzatti, Børge Grønne Nordestgaard et al. · 2009 · Circulation Cardiovascular Quality and Outcomes
96. The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension
    Hack‐Lyoung Kim, Eun Mi Lee, Shin Young Ahn, Kwang‐Il Kim, Hyeon Chang Kim, Ju Han Kim, Hae‐Young Lee, Jang Hoon Lee, Jong‐Moo Park, Eun Joo Cho et al. · 2023 · Clinical Hypertension
97. Mechanisms involved in the association between peridontal diseases and cardiovascular disease
    Rui Campante Teles, C‐Y Wang · 2011 · Oral Diseases
98. Statins in the Treatment of Dyslipidemia in the Presence of Elevated Liver Aminotransferase Levels: A Therapeutic Dilemma
    Rossana M. Calderon, Luigi X. Cubeddu, Ronald B Goldberg, Eugene R. Schiff · 2010 · Mayo Clinic Proceedings
99. The metabolic syndrome: common origins of a multifactorial disorder
    Kimberley D. Bruce, Christopher D. Byrne · 2009 · Postgraduate Medical Journal
100. C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death
     the PAIS investigators, Heleen M. den Hertog, Johannis A van Rossum, H. Bart van der Worp, H. Maarten A. van Gemert, Róbert de Jonge, Peter J. Koudstaal, Diederik W.J. Dippel · 2009 · Journal of Neurology